Intrinsic value of ACADIA Pharmaceuticals Inc. (ACAD)
Live fair value data for ACADIA Pharmaceuticals Inc. (ACAD) is currently unavailable. Please check again shortly.
Current Price: $365.00
Valuation: Overvalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is ACADIA Pharmaceuticals Inc. (ACAD) undervalued or overvalued?
Based on the current model output, ACADIA Pharmaceuticals Inc. appears to be overvalued with a downside of 22.00%.
Fair value vs market price — ACADIA Pharmaceuticals Inc. (ACAD)
Unlock premium access to view the live fair value comparison against current market price for ACAD.
Frequently Asked Questions - ACAD
How is ACAD intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ACAD.
Is ACAD undervalued or overvalued right now?
ACAD is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ACAD: open their intrinsic value pages.